肾移植可改善老年受者的健康相关生活质量。
Kidney Transplantation Improves Health-Related Quality of Life in Older Recipients.
机构信息
Department of Internal Medicine, Division of Nephrology, University Medical Center Groningen and University of Groningen, Groningen, Netherlands.
Department of Internal Medicine, Division of Geriatrics, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
出版信息
Transpl Int. 2024 Apr 15;37:12071. doi: 10.3389/ti.2024.12071. eCollection 2024.
Kidney transplantation is the best treatment for kidney failure in older patients. However, little is known regarding changes in health-related quality of life (HRQoL) from before to after transplantation and determinants of HRQoL in older kidney transplant recipients (KTR). We studied both, using data of older (≥65 years) patients waitlisted for kidney transplantation and older KTR 1 year after transplantation from the TransplantLines Biobank and Cohort Study. HRQoL was assessed using the SF-36 questionnaire. We included 145 older waitlisted patients (68% male, age 70 ± 4 years) and 115 older KTR at 1 year after transplantation (73% male, age 70 ± 4 years). Both mental (48.5 ± 8.4 versus 51.2 ± 7.7, = 0.009) and physical (47.4 ± 8.5 versus 52.1 ± 7.2, < 0.001) HRQoL were higher among included KTR, compared to the waitlisted patients. In paired analyses among 46 patients with HRQoL-data both before and after transplantation, there was a trend towards increased mental HRQoL (49.1 ± 8.4 to 51.6 ± 7.5, = 0.054), and significantly increased physical HRQoL (48.1 ± 8.0 to 52.4 ± 6.7, = 0.001) after transplantation. Among all assessed factors, the number of patient-reported immunosuppressive drug-related side effects was most strongly negatively associated with both mental and physical HRQoL. In conclusion, HRQoL is significantly higher among older KTR after kidney transplantation compared to older waitlisted patients.
肾移植是治疗老年肾衰竭患者的最佳方法。然而,对于移植前后健康相关生活质量(HRQoL)的变化以及老年肾移植受者(KTR)的 HRQoL 决定因素知之甚少。我们使用等待肾移植的老年(≥65 岁)患者和移植后 1 年的老年 KTR 的 TransplantLines 生物库和队列研究的数据来研究这两个问题。使用 SF-36 问卷评估 HRQoL。我们纳入了 145 名等待移植的老年患者(68%为男性,年龄 70 ± 4 岁)和 115 名移植后 1 年的老年 KTR(73%为男性,年龄 70 ± 4 岁)。与等待移植的患者相比,包括 KTR 在内的患者的精神(48.5 ± 8.4 比 51.2 ± 7.7, = 0.009)和身体(47.4 ± 8.5 比 52.1 ± 7.2,< 0.001)HRQoL 更高。在有 HRQoL 数据的 46 名患者的配对分析中,在移植前后都存在精神 HRQoL 增加的趋势(49.1 ± 8.4 比 51.6 ± 7.5, = 0.054),并且移植后身体 HRQoL 显著增加(48.1 ± 8.0 比 52.4 ± 6.7, = 0.001)。在所有评估的因素中,患者报告的免疫抑制药物相关副作用的数量与精神和身体 HRQoL 呈最强的负相关。总之,与等待移植的老年患者相比,老年肾移植受者在肾移植后 HRQoL 显著更高。